With WHO prequalification, global health organizations can consider the Aptima HIV-1 Quant Dx for public-sector procurement in resource-limited countries.
The study is the first to demonstrate the design features and operational characteristics of Cepheid's Xpert MTB/RIF Ultra assay.
Using the grant funding, the investigators are aiming to advance the precision diagnosis and treatment of lung cancer.
With genotyping data from tens of thousands of individuals with or without lung cancer, researchers identified eight known and 10 new loci associated with lung cancer.
The kit is a qualitative nucleic acid assay designed to test for Zika, dengue, and chikungunya viruses simultaneously.
Researchers have sequenced and analyzed a genome assembly for a Zika virus reference strain from French Polynesia that might be used as part of diagnostic assays.
The RealStar Zika Virus RT-PCR Kit 1.0 has been listed by the World Health Organization as eligible for procurement agencies and member states.
The GenomeWeb Index fell half a percent in June, underperforming the Dow Jones Industrial Average, but far outpacing the Nasdaq and Nasdaq Biotech Index.
Prequalification now enables procurement in numerous countries within sub-Saharan Africa that have regulations requiring this type of oversight.
The World Health Organization has begun looking for a new director general, Stat News says.
Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.
The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.
In Science this week: genetic overlap among many psychiatric disorders, and more.
The Economist writes that an increasing number of scientific journals don't do peer review.